Dysregulation of Pin1 has been identified in the pathogenesis of AD and thus recognized as a potential target for future therapeutics (Pastorino, Sun, Lu, Zhou, & Balastik, 2006). This evidence concerns the gene PIN1 and Alzheimer disease.